Westmead Hospital, University of Sydney
ACRF awarded the Westmead Institute $1.02 million as part of an $8.75 million project to build an integrated research centre at the Westmead Hospital in Sydney
The overall research directions of the Westmead Institute are the genetic, molecular and cellular basis of virus infections, the immune response, cancer and liver diseases. The principal research technologies centre on molecular and cell biological techniques. These themes are directed to address disease pathogenesis.
The Westmead Institute of Cancer Research is involved in research into a number of important cancers and has been acknowledged as an international leader in melanoma studies – particularly identifying genes linked with melanoma.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.